1. Home
  2. FOXO vs SLXN Comparison

FOXO vs SLXN Comparison

Compare FOXO & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXO
  • SLXN
  • Stock Information
  • Founded
  • FOXO 2019
  • SLXN 2008
  • Country
  • FOXO United States
  • SLXN Israel
  • Employees
  • FOXO N/A
  • SLXN N/A
  • Industry
  • FOXO Retail: Computer Software & Peripheral Equipment
  • SLXN
  • Sector
  • FOXO Technology
  • SLXN
  • Exchange
  • FOXO Nasdaq
  • SLXN NYSE
  • Market Cap
  • FOXO 8.0M
  • SLXN 5.0M
  • IPO Year
  • FOXO N/A
  • SLXN N/A
  • Fundamental
  • Price
  • FOXO $0.22
  • SLXN $1.26
  • Analyst Decision
  • FOXO
  • SLXN Strong Buy
  • Analyst Count
  • FOXO 0
  • SLXN 1
  • Target Price
  • FOXO N/A
  • SLXN $9.00
  • AVG Volume (30 Days)
  • FOXO 13.4M
  • SLXN 32.1M
  • Earning Date
  • FOXO 11-19-2024
  • SLXN 02-21-2025
  • Dividend Yield
  • FOXO N/A
  • SLXN N/A
  • EPS Growth
  • FOXO N/A
  • SLXN N/A
  • EPS
  • FOXO N/A
  • SLXN N/A
  • Revenue
  • FOXO $1,341,000.00
  • SLXN N/A
  • Revenue This Year
  • FOXO N/A
  • SLXN N/A
  • Revenue Next Year
  • FOXO N/A
  • SLXN N/A
  • P/E Ratio
  • FOXO N/A
  • SLXN N/A
  • Revenue Growth
  • FOXO 196.03
  • SLXN N/A
  • 52 Week Low
  • FOXO $0.13
  • SLXN $0.21
  • 52 Week High
  • FOXO $1.30
  • SLXN $13.56
  • Technical
  • Relative Strength Index (RSI)
  • FOXO 41.75
  • SLXN N/A
  • Support Level
  • FOXO $0.22
  • SLXN N/A
  • Resistance Level
  • FOXO $0.27
  • SLXN N/A
  • Average True Range (ATR)
  • FOXO 0.03
  • SLXN 0.00
  • MACD
  • FOXO 0.00
  • SLXN 0.00
  • Stochastic Oscillator
  • FOXO 7.30
  • SLXN 0.00

About FOXO FOXO Technologies Inc.

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

Share on Social Networks: